rs147791932
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_006306.4(SMC1A):c.855-15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000528 in 1,207,494 control chromosomes in the GnomAD database, including 5 homozygotes. There are 178 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006306.4 intron
Scores
Clinical Significance
Conservation
Publications
- Cornelia de Lange syndrome 2Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- developmental and epileptic encephalopathy, 85, with or without midline brain defectsInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cornelia de Lange syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00307 AC: 343AN: 111589Hom.: 4 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000740 AC: 135AN: 182501 AF XY: 0.000476 show subpopulations
GnomAD4 exome AF: 0.000268 AC: 294AN: 1095852Hom.: 1 Cov.: 30 AF XY: 0.000216 AC XY: 78AN XY: 361298 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00307 AC: 343AN: 111642Hom.: 4 Cov.: 22 AF XY: 0.00295 AC XY: 100AN XY: 33842 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
- -
Congenital muscular hypertrophy-cerebral syndrome Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at